Lv51
940 积分 2024-02-12 加入
ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis
5天前
已完结
Efficacy and Safety of Efgartigimod for Patients With Myasthenia Gravis in a Real‐World Cohort of 77 Patients
8天前
已完结
Intensive care management of patients with viral encephalitis
17天前
已完结
Varicella‐zoster virus‐related neurological complications: From infection to immunomodulatory therapies
17天前
已完结
Human pegivirus identified in severe myelitis and optic neuritis in immunocompromised patients: A pathogenic role for a forgotten virus?
29天前
已完结
A systematic review of efgartigimod as an effective treatment for myasthenic crisis
1个月前
已完结
Efgartigimod for generalized myasthenia gravis: A multicenter real‐world cohort study in China
1个月前
已完结
Real-World experience with efgartigimod in patients with myasthenia gravis
1个月前
已完结
Clinical outcome and peripheral CD4+ T profile in impending myasthenic crisis: A prospective cohort study
1个月前
已完结
Is the treatment of myasthenia gravis improving?
3个月前
已关闭
皖公网安备34019202002308
